Ken Fisher’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Ken Fisher’s Portfolio XBI Stock Details XBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,435	Closed	-$202K	–	977
2020 Q4	$202K	Buy	+1,435	New	+$184K	﹤0.01%	877
2020 Q3	–	Sell	-2,573	Closed	-$288K	–	895
2020 Q2	$288K	Buy	+2,573	New	+$253K	﹤0.01%	730

Other funds holding XBI

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Ken Fisher's XBI Position: Q1 2021 in Review

Ken Fisher sold out of State Street SPDR S&P Biotech ETF (XBI) in Q1 2021, closing a stake of 1,435 shares — an estimated $202K sold.

Ken Fisher first reported a position in XBI in Q2 2020 and held it in 2 quarters. The position peaked at $288K in Q2 2020. 644 funds tracked by Wall St. Rank hold XBI as of Q1 2021.

Ken Fisher reported no remaining State Street SPDR S&P Biotech ETF position as of Q1 2021 after selling out during the quarter.
Ken Fisher sold 1,435 State Street SPDR S&P Biotech ETF shares in Q1 2021, an estimated $202K.
Ken Fisher first reported a position in State Street SPDR S&P Biotech ETF in Q2 2020 and held it in 2 quarters.
Ken Fisher's State Street SPDR S&P Biotech ETF position peaked at $288K in Q2 2020.
644 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2021.

Based on Fisher Asset Management's 13F filing for Q1 2021, filed 27 Apr 2021.